CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
59.80
+1.20 (2.05%)
Feb 21, 2025, 2:59 PM CST
-8.28%
Market Cap 12.80B
Revenue (ttm) 1.08M
Net Income (ttm) -255.25M
Shares Out 214.01M
EPS (ttm) -1.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 289,476
Average Volume 547,057
Open 58.20
Previous Close 58.60
Day's Range 58.20 - 61.30
52-Week Range 49.00 - 72.30
Beta 0.12
RSI 59.79
Earnings Date Mar 21, 2025

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.